New York state wants its prescription drug money back—or else image

USA Today, May 18, 2017
Julie Appleby, quoting Rachel Sachs (Academic Fellow Alumna)

Links

Read the full article

From the article:

New York’s Medicaid program, for example, has seen its drug spending rise on average 8% each year over the past three years, after taking into account existing rebates. The program, which uses federal and state funds, serves more than 6 million people. Drugs represent about 5% of the cost of the program — with the state paying out $3 billion last year for prescriptions, Medicaid officials said.

Though its law is unique, New York’s efforts are “in keeping with the mood in a number of other states,” said Rachel Sachs, an associate professor at Washington University-St. Louis School of Law who studies intellectual property, health law and food and drug regulation.

Read more here!

bioethics fda health care finance health care reform health law policy pharmaceuticals rachel sachs regulation